Regencell Bioscience Holdings stock price

NASDAQ:RGC · Nasdaq · Healthcare · sector #16
$10.80+3.35%Oct 21 close
Loading chart…

Regencell Bioscience Holdings's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is RGC.

Regencell Bioscience Holdings last closed at $10.80 (+3.35%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -397.7×. Its overall grade ranks 177 of 727 stocks in Healthcare.

About this company

Regencell Bioscience Holdings last closed at $10.80 (+3.35%) on 2026-10-21. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A- · 177/727

Valuation grade A+

Details →

Related stocks

  • AstraZenecaCompetitor
  • PfizerCompetitor
  • NovartisCompetitor
Details →
About Regencell Bioscience Holdings
What technical signals does Regencell Bioscience Holdings (RGC) have?
Regencell Bioscience Holdings current technical signals: no active technical signal.
Is Regencell Bioscience Holdings a cup-and-handle pattern?
No. Regencell Bioscience Holdings has no valid Cup signal right now.
What published figures are available for Regencell Bioscience Holdings?
Market cap: $5.34B. Trailing 12 months PER: -397.7×. Latest quarter PBR: 400.22×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about Regencell Bioscience Holdings, or open the plan table on the main site.

Ask Q about Regencell Bioscience Holdings.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Regencell Bioscience Holdings notifications

Quantus Signal · live data · not investment advice · Privacy Policy